Search research articles
Contact Us
Filters
Showing results (41-50 of 64) with videos related to
Page
of 7
Sort By:
Journal of Vascular Surgery
|
February 1, 1987
Biomaterial pretreatment with ECGF to augment endothelial cell proliferation
H P Greisler, J J Klosak, J W Dennis, et al.
European Journal of Medical Research
|
January 15, 2005
GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
P J Bastian, J Ellinger, D Schmidt, et al.
Der Urologe. Ausg. A
|
January 23, 2008
[Pediatric renal cell carcinoma. A rare differential diagnosis of Wilms' tumor]
N Fischer, P J Bastian, J Ellinger, et al.
Der Urologe. Ausg. A
|
January 21, 2009
[A critical assessment of phytotherapy for prostate cancer]
F G E Perabo, E C von Löw, R Siener, et al.
Der Urologe. Ausg. A
|
October 15, 2010
[Pyrosequencing in uro-oncology: applications in prostate cancer]
T C Stadler, A Jung, B Schlenker, et al.
European Journal of Medical Research
|
May 22, 2007
Prostate cancer tissue is masked by bicalutamide: a case report
J Ellinger, P J Bastian, K Biermann, et al.
Prostate Cancer and Prostatic Diseases
|
October 10, 2007
Soy isoflavone genistein in prevention and treatment of prostate cancer
F G E Perabo, E C Von Löw, J Ellinger, et al.
Journal of Vascular Surgery
|
May 1, 1988
Polyglactin 910/polydioxanone bicomponent totally resorbable vascular prostheses
H P Greisler, E D Endean, J J Klosak, et al.
ASAIO Transactions
|
July 1, 1989
Platelet interactions with heparin binding growth factor and fibronectin
H P Greisler, J J Klosak, S Steinam, et al.
Der Urologe. Ausg. A
|
July 25, 2008
[CpG island hypermethylation of the DNA. Perspectives of a molecular biomarker for prostate cancer]
P J Bastian, J Ellinger, A von Rücker, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 64) with videos related to
Sort By:
Page
of 7
Journal of Vascular Surgery
|
February 1, 1987
Biomaterial pretreatment with ECGF to augment endothelial cell proliferation
H P Greisler, J J Klosak, J W Dennis, et al.
European Journal of Medical Research
|
January 15, 2005
GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
P J Bastian, J Ellinger, D Schmidt, et al.
Der Urologe. Ausg. A
|
January 23, 2008
[Pediatric renal cell carcinoma. A rare differential diagnosis of Wilms' tumor]
N Fischer, P J Bastian, J Ellinger, et al.
Der Urologe. Ausg. A
|
January 21, 2009
[A critical assessment of phytotherapy for prostate cancer]
F G E Perabo, E C von Löw, R Siener, et al.
Der Urologe. Ausg. A
|
October 15, 2010
[Pyrosequencing in uro-oncology: applications in prostate cancer]
T C Stadler, A Jung, B Schlenker, et al.
European Journal of Medical Research
|
May 22, 2007
Prostate cancer tissue is masked by bicalutamide: a case report
J Ellinger, P J Bastian, K Biermann, et al.
Prostate Cancer and Prostatic Diseases
|
October 10, 2007
Soy isoflavone genistein in prevention and treatment of prostate cancer
F G E Perabo, E C Von Löw, J Ellinger, et al.
Journal of Vascular Surgery
|
May 1, 1988
Polyglactin 910/polydioxanone bicomponent totally resorbable vascular prostheses
H P Greisler, E D Endean, J J Klosak, et al.
ASAIO Transactions
|
July 1, 1989
Platelet interactions with heparin binding growth factor and fibronectin
H P Greisler, J J Klosak, S Steinam, et al.
Der Urologe. Ausg. A
|
July 25, 2008
[CpG island hypermethylation of the DNA. Perspectives of a molecular biomarker for prostate cancer]
P J Bastian, J Ellinger, A von Rücker, et al.
Page
of 7